(Q46689922)

English

Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients? (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

adaptive radiation therapy

0 references

0 references

author name string

Leyla Kilic

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Cetin Ordu

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Meltem Ekenel

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Ibrahim Yildiz

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Serkan Keskin

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Fatma Sen

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Zeynep Gural

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Oktar Asoglu

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Ahmet Kizir

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Faruk Aykan

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

publication date

23 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

30

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

660

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Chemotherapy in gastric cancer: a review and updated meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0660-2

21 January 2018

Metastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23877872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23877872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modality treatment of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23877872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23877872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification

1 reference

https://pubmed.ncbi.nlm.nih.gov/23877872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T N M classification for stomach cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23877872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23877872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-013-0660-2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/23877872

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46689922&oldid=2208025388"